Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

G Juliusson1, D G Oscier, M Fitchett

  • 1Department of Medicine, Karolinska Institute, Huddinge Hospital, Sweden.

The New England Journal of Medicine
|September 13, 1990
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Leukemia·2026
Same author

Control of structure and spin texture in the van der Waals layered magnet CrSBr.

Nature communications·2022
Same author

Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.

Leukemia·2016
Same author

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Leukemia & lymphoma·2016
Same author

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Leukemia·2016
Same author

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease.

Leukemia·2016

Chromosomal abnormalities impact survival in B-cell chronic lymphocytic leukemia (CLL). Karyotype analysis offers prognostic insights beyond clinical data for CLL patients.

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • Chromosomal abnormalities are known prognostic factors in acute leukemia.
  • Their role in B-cell chronic lymphocytic leukemia (CLL) prognosis remains debated.

Purpose of the Study:

  • To investigate the prognostic value of chromosomal abnormalities in B-cell CLL.
  • To correlate specific chromosomal defects with patient survival outcomes.

Main Methods:

  • Cytogenetic analysis of banded metaphases from 433 B-cell CLL patients across five European centers.
  • Culturing of blood mononuclear cells with B-cell mitogens.

Main Results:

  • 218 out of 391 evaluable patients exhibited clonal chromosomal changes.

Related Experiment Videos

  • Trisomy 12 and abnormalities of chromosomes 13q and 14q were most frequent.
  • Patients with normal karyotypes had >15 years median survival vs. 7.7 years for those with clonal changes.
  • Complex karyotypes and specific abnormalities (e.g., 14q, trisomy 12) were associated with poorer survival.
  • High percentage of metaphases with abnormalities correlated with poor survival.

    • Conclusions:

    • Chromosomal analysis is a valuable prognostic tool in B-cell CLL.
    • Karyotype findings provide additional prognostic information beyond established clinical data.
    • Identified prognostic variables include age, sex, chromosomal abnormality percentage, and Binet stage.